vs
西联汇款（AFG）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
西联汇款的季度营收约是瑞思迈的1.4倍（$2.1B vs $1.4B），瑞思迈净利率更高（27.6% vs 14.5%，领先13.1%），瑞思迈同比增速更快（11.0% vs -4.0%），过去两年瑞思迈的营收复合增速更高（9.0% vs 4.0%）
西联汇款是总部位于美国科罗拉多州丹佛市的跨国金融服务企业，为全球个人及商业客户提供跨境汇款、支付等多元金融解决方案，在全球绝大多数国家和地区拥有覆盖广泛的服务网络。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
AFG vs RMD — 直观对比
营收规模更大
AFG
是对方的1.4倍
$1.4B
营收增速更快
RMD
高出15.0%
-4.0%
净利率更高
RMD
高出13.1%
14.5%
两年增速更快
RMD
近两年复合增速
4.0%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $2.1B | $1.4B |
| 净利润 | $299.0M | $392.6M |
| 毛利率 | — | 61.8% |
| 营业利润率 | 18.4% | 34.6% |
| 净利率 | 14.5% | 27.6% |
| 营收同比 | -4.0% | 11.0% |
| 净利润同比 | 17.3% | 13.9% |
| 每股收益（稀释后） | $3.59 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AFGRMD
| Q4 25 | $2.1B | $1.4B | ||
| Q3 25 | $2.3B | $1.3B | ||
| Q2 25 | $1.9B | $1.3B | ||
| Q1 25 | $1.9B | $1.3B | ||
| Q4 24 | $2.1B | $1.3B | ||
| Q3 24 | $2.4B | $1.2B | ||
| Q2 24 | $1.9B | $1.2B | ||
| Q1 24 | $1.9B | $1.2B |
净利润AFGRMD
| Q4 25 | $299.0M | $392.6M | ||
| Q3 25 | $215.0M | $348.5M | ||
| Q2 25 | $174.0M | $379.7M | ||
| Q1 25 | $154.0M | $365.0M | ||
| Q4 24 | $255.0M | $344.6M | ||
| Q3 24 | $181.0M | $311.4M | ||
| Q2 24 | $209.0M | $292.2M | ||
| Q1 24 | $242.0M | $300.5M |
毛利率AFGRMD
| Q4 25 | — | 61.8% | ||
| Q3 25 | — | 61.5% | ||
| Q2 25 | — | 60.8% | ||
| Q1 25 | — | 59.3% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | — | 58.6% | ||
| Q2 24 | — | 58.5% | ||
| Q1 24 | — | 57.9% |
营业利润率AFGRMD
| Q4 25 | 18.4% | 34.6% | ||
| Q3 25 | 11.5% | 33.4% | ||
| Q2 25 | 11.9% | 33.7% | ||
| Q1 25 | 10.6% | 33.0% | ||
| Q4 24 | 14.9% | 32.5% | ||
| Q3 24 | 9.7% | 31.6% | ||
| Q2 24 | 14.3% | 31.2% | ||
| Q1 24 | 15.9% | 31.3% |
净利率AFGRMD
| Q4 25 | 14.5% | 27.6% | ||
| Q3 25 | 9.2% | 26.1% | ||
| Q2 25 | 9.0% | 28.2% | ||
| Q1 25 | 8.3% | 28.3% | ||
| Q4 24 | 11.9% | 26.9% | ||
| Q3 24 | 7.6% | 25.4% | ||
| Q2 24 | 11.0% | 23.9% | ||
| Q1 24 | 12.7% | 25.1% |
每股收益（稀释后）AFGRMD
| Q4 25 | $3.59 | $2.68 | ||
| Q3 25 | $2.58 | $2.37 | ||
| Q2 25 | $2.07 | $2.58 | ||
| Q1 25 | $1.84 | $2.48 | ||
| Q4 24 | $3.03 | $2.34 | ||
| Q3 24 | $2.16 | $2.11 | ||
| Q2 24 | $2.49 | $1.97 | ||
| Q1 24 | $2.89 | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.7B | $1.4B |
| 总债务越低越好 | $1.8B | $403.9M |
| 股东权益账面价值 | $4.8B | $6.3B |
| 总资产 | $32.6B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.38× | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资AFGRMD
| Q4 25 | $1.7B | $1.4B | ||
| Q3 25 | $1.8B | $1.4B | ||
| Q2 25 | $1.3B | $1.2B | ||
| Q1 25 | $1.3B | $932.7M | ||
| Q4 24 | $1.4B | $521.9M | ||
| Q3 24 | $1.3B | $426.4M | ||
| Q2 24 | $1.1B | $238.4M | ||
| Q1 24 | $1.1B | $237.9M |
总债务AFGRMD
| Q4 25 | $1.8B | $403.9M | ||
| Q3 25 | $1.8B | $408.7M | ||
| Q2 25 | $1.5B | $658.4M | ||
| Q1 25 | $1.5B | $663.1M | ||
| Q4 24 | $1.5B | $662.9M | ||
| Q3 24 | $1.5B | $667.6M | ||
| Q2 24 | $1.5B | $697.3M | ||
| Q1 24 | $1.5B | $997.0M |
股东权益AFGRMD
| Q4 25 | $4.8B | $6.3B | ||
| Q3 25 | $4.7B | $6.1B | ||
| Q2 25 | $4.5B | $6.0B | ||
| Q1 25 | $4.4B | $5.5B | ||
| Q4 24 | $4.5B | $5.3B | ||
| Q3 24 | $4.7B | $5.2B | ||
| Q2 24 | $4.4B | $4.9B | ||
| Q1 24 | $4.2B | $4.6B |
总资产AFGRMD
| Q4 25 | $32.6B | $8.5B | ||
| Q3 25 | $33.8B | $8.3B | ||
| Q2 25 | $30.7B | $8.2B | ||
| Q1 25 | $30.3B | $7.6B | ||
| Q4 24 | $30.8B | $7.1B | ||
| Q3 24 | $32.6B | $7.2B | ||
| Q2 24 | $29.9B | $6.9B | ||
| Q1 24 | $30.0B | $6.8B |
负债/权益比AFGRMD
| Q4 25 | 0.38× | 0.06× | ||
| Q3 25 | 0.38× | 0.07× | ||
| Q2 25 | 0.33× | 0.11× | ||
| Q1 25 | 0.34× | 0.12× | ||
| Q4 24 | 0.33× | 0.13× | ||
| Q3 24 | 0.31× | 0.13× | ||
| Q2 24 | 0.34× | 0.14× | ||
| Q1 24 | 0.35× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $784.0M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | — | $311.2M |
| 自由现金流率自由现金流/营收 | — | 21.9% |
| 资本支出强度资本支出/营收 | — | 2.0% |
| 现金转化率经营现金流/净利润 | 2.62× | 0.87× |
| 过去12个月自由现金流最近4个季度 | — | $1.8B |
8季度趋势，按日历期对齐
经营现金流AFGRMD
| Q4 25 | $784.0M | $339.7M | ||
| Q3 25 | $216.0M | $457.3M | ||
| Q2 25 | $191.0M | $538.8M | ||
| Q1 25 | $342.0M | $578.7M | ||
| Q4 24 | $674.0M | $308.6M | ||
| Q3 24 | $459.0M | $325.5M | ||
| Q2 24 | $-88.0M | $440.1M | ||
| Q1 24 | $107.0M | $402.0M |
自由现金流AFGRMD
| Q4 25 | — | $311.2M | ||
| Q3 25 | — | $414.4M | ||
| Q2 25 | — | $508.2M | ||
| Q1 25 | — | $557.9M | ||
| Q4 24 | — | $288.0M | ||
| Q3 24 | — | $307.7M | ||
| Q2 24 | — | $415.2M | ||
| Q1 24 | — | $380.8M |
自由现金流率AFGRMD
| Q4 25 | — | 21.9% | ||
| Q3 25 | — | 31.0% | ||
| Q2 25 | — | 37.7% | ||
| Q1 25 | — | 43.2% | ||
| Q4 24 | — | 22.5% | ||
| Q3 24 | — | 25.1% | ||
| Q2 24 | — | 33.9% | ||
| Q1 24 | — | 31.8% |
资本支出强度AFGRMD
| Q4 25 | — | 2.0% | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | — | 2.3% | ||
| Q1 25 | — | 1.6% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | — | 1.8% |
现金转化率AFGRMD
| Q4 25 | 2.62× | 0.87× | ||
| Q3 25 | 1.00× | 1.31× | ||
| Q2 25 | 1.10× | 1.42× | ||
| Q1 25 | 2.22× | 1.59× | ||
| Q4 24 | 2.64× | 0.90× | ||
| Q3 24 | 2.54× | 1.05× | ||
| Q2 24 | -0.42× | 1.51× | ||
| Q1 24 | 0.44× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AFG
| Property And Casualty Insurance | $2.0B | 96% |
| Other | $83.0M | 4% |
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
